Samsara BioCapital GP, LLC - 13 Mar 2025 Form 4 Insider Report for Mineralys Therapeutics, Inc. (MLYS)

Role
10%+ Owner
Signature
Samsara BioCapital GP, LLC, By /s/ Srinivas Akkaraju, Managing Member
Issuer symbol
MLYS
Transactions as of
13 Mar 2025
Net transactions value
+$8,100,000
Form type
4
Filing time
17 Mar 2025, 21:05:47 UTC
Previous filing
27 Nov 2024
Next filing
25 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MLYS Common Stock Purchase $8,100,000 +600,000 +12% $13.50 5,674,916 13 Mar 2025 By Samsara BioCapital, L.P. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Samsara BioCapital GP, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Securities are directly held by Samsara BioCapital, L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara LLC") is the general partner of Samsara LP and may be deemed to beneficially own the securities held by Samsara LP. Samsara LLC disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein.